{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:35:18Z","timestamp":1758044118923,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"DOI":"10.7759\/cureus.92130","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:58:31Z","timestamp":1757674711000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Cortisol and Aldosterone in Hypertensive Nephropathy"],"prefix":"10.7759","author":[{"given":"Qasim","family":"Javed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qazi Taqweem","family":"ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wardah","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Irshad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Mamoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimoor","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Afnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.690487","article-title":"Disease burden of chronic kidney disease due to hypertension from 1990 to 2019: a global analysis","volume":"8","author":"Chen A","year":"2021","unstructured":"Chen A, Zou M, Young CA, Zhu W, Chiu HC, Jin G, Tian L. Disease burden of chronic kidney disease due to hypertension from 1990 to 2019: a global analysis. Front Med (Lausanne). 2021, 8:690487. 10.3389\/fmed.2021.690487","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092138","article-title":"Molecular mechanisms of kidney injury and repair in arterial hypertension","volume":"20","author":"Sievers LK","year":"2019","unstructured":"Sievers LK, Eckardt KU. Molecular mechanisms of kidney injury and repair in arterial hypertension. Int J Mol Sci. 2019, 20:10.3390\/ijms20092138","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.006","article-title":"The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis","volume":"12","author":"Luther JM","year":"2022","unstructured":"Luther JM, Fogo AB. The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis. Kidney Int Suppl (2011). 2022, 12:63-8. 10.1016\/j.kisu.2021.11.006","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.967317","article-title":"Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease","volume":"13","author":"Wu Y","year":"2022","unstructured":"Wu Y, Lin H, Tao Y, Xu Y, Chen J, Jia Y, Zheng Z. Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease. Front Pharmacol. 2022, 13:967317. 10.3389\/fphar.2022.967317","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15747","article-title":"Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease","volume":"179","author":"Kintscher U","year":"2022","unstructured":"Kintscher U, Bakris GL, Kolkhof P. Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. Br J Pharmacol. 2022, 179:3220-34. 10.1111\/bph.15747","journal-title":"Br J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.027","article-title":"Mineralocorticoid receptor antagonism in chronic kidney disease","volume":"6","author":"Georgianos PI","year":"2021","unstructured":"Georgianos PI, Agarwal R. Mineralocorticoid receptor antagonism in chronic kidney disease. Kidney Int Rep. 2021, 6:2281-91. 10.1016\/j.ekir.2021.05.027","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14733","article-title":"Hypothalamic-pituitary-adrenal axis activity and vascular function in healthy adults","volume":"97","author":"Radhakutty A","year":"2022","unstructured":"Radhakutty A, Lee T, Mangelsdorf BL, Drake SM, Burt MG. Hypothalamic-pituitary-adrenal axis activity and vascular function in healthy adults. Clin Endocrinol (Oxf). 2022, 97:64-71. 10.1111\/cen.14733","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03698-9","article-title":"Apparent mineralocorticoid excess: comprehensive overview of molecular genetics","volume":"20","author":"Lu YT","year":"2022","unstructured":"Lu YT, Zhang D, Zhang QY, Zhou ZM, Yang KQ, Zhou XL, Peng F. Apparent mineralocorticoid excess: comprehensive overview of molecular genetics. J Transl Med. 2022, 20:500. 10.1186\/s12967-022-03698-9","journal-title":"J Transl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754239","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease","volume":"12","author":"Kawanami D","year":"2021","unstructured":"Kawanami D, Takashi Y, Muta Y, Oda N, Nagata D, Takahashi H, Tanabe M. Mineralocorticoid receptor antagonists in diabetic kidney disease. Front Pharmacol. 2021, 12:754239. 10.3389\/fphar.2021.754239","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-022-02732-5","article-title":"Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology","volume":"474","author":"Pearce D","year":"2022","unstructured":"Pearce D, Manis AD, Nesterov V, Korbmacher C. Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology. Pflugers Arch. 2022, 474:869-84. 10.1007\/s00424-022-02732-5","journal-title":"Pflugers Arch"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.16","article-title":"Aldosterone\/NaCl-induced renal and cardiac fibrosis is modulated by TGF-\u03b2 responsiveness of T cells","volume":"34","author":"Schreier B","year":"2011","unstructured":"Schreier B, Rabe S, Schneider B, et al.. Aldosterone\/NaCl-induced renal and cardiac fibrosis is modulated by TGF-\u03b2 responsiveness of T cells. Hypertens Res. 2011, 34:623-9. 10.1038\/hr.2011.16","journal-title":"Hypertens Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.08.024","article-title":"Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx","volume":"95","author":"Butler MJ","year":"2019","unstructured":"Butler MJ, Ramnath R, Kadoya H, et al.. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx. Kidney Int. 2019, 95:94-107. 10.1016\/j.kint.2018.08.024","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020207","article-title":"Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial","volume":"33","author":"Provenzano M","year":"2022","unstructured":"Provenzano M, Puchades MJ, Garofalo C, et al.. Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial. J Am Soc Nephrol. 2022, 33:1569-80. 10.1681\/ASN.2022020207","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1075809","article-title":"Cortisol excess in chronic kidney disease - a review of changes and impact on mortality","volume":"13","author":"Sagmeister MS","year":"2022","unstructured":"Sagmeister MS, Harper L, Hardy RS. Cortisol excess in chronic kidney disease - a review of changes and impact on mortality. Front Endocrinol (Lausanne). 2022, 13:1075809. 10.3389\/fendo.2022.1075809","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2016.137","article-title":"Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension","volume":"40","author":"Shibata S","year":"2017","unstructured":"Shibata S, Ishizawa K, Uchida S. Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension. Hypertens Res. 2017, 40:221-5. 10.1038\/hr.2016.137","journal-title":"Hypertens Res"},{"key":"ref16","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","unstructured":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024, 105.117-314.","journal-title":"Kidney Int"},{"key":"ref17","article-title":"Perceived stress in a probability sample of the United States","author":"Cohen S","year":"1988","unstructured":"Cohen S, Williamson GM. Perceived stress in a probability sample of the United States. The Social Psychology of Health. Spacapan S, Oskamp S (ed): Sage, Newbury Park; 1988. 31-67."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.48742","article-title":"The association of serum cortisol level with microalbuminuria in patients with type 2 diabetes and prediabetes","volume":"17","author":"Zhang X","year":"2020","unstructured":"Zhang X, Deng X, Zhou J, et al.. The association of serum cortisol level with microalbuminuria in patients with type 2 diabetes and prediabetes. Int J Med Sci. 2020, 17:2998-3004. 10.7150\/ijms.48742","journal-title":"Int J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06031-1","article-title":"Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists","volume":"67","author":"Savarese G","year":"2024","unstructured":"Savarese G, Lindberg F, Filippatos G, Butler J, Anker SD. Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists. Diabetologia. 2024, 67:246-62. 10.1007\/s00125-023-06031-1","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73638-4","article-title":"The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial","volume":"10","author":"Minakuchi H","year":"2020","unstructured":"Minakuchi H, Wakino S, Urai H, et al.. The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial. Sci Rep. 2020, 10:16626. 10.1038\/s41598-020-73638-4","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12707","article-title":"Morning blood pressure surge as a predictor of development of chronic kidney disease","volume":"18","author":"Turak O","year":"2016","unstructured":"Turak O, Afsar B, Siriopol D, et al.. Morning blood pressure surge as a predictor of development of chronic kidney disease. J Clin Hypertens (Greenwich). 2016, 18:444-8. 10.1111\/jch.12707","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003049","article-title":"Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study","volume":"40","author":"Lin M","year":"2022","unstructured":"Lin M, Heizhati M, Gan L, et al.. Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study. J Hypertens. 2022, 40:561-9. 10.1097\/HJH.0000000000003049","journal-title":"J Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-5572","article-title":"CIRMI-a new term for a concept worthy of further exploration: a narrative review","volume":"10","author":"Nethathe GD","year":"2022","unstructured":"Nethathe GD, Lipman J, Anderson R, Feldman C. CIRMI-a new term for a concept worthy of further exploration: a narrative review. Ann Transl Med. 2022, 10:646. 10.21037\/atm-21-5572","journal-title":"Ann Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402290-the-role-of-cortisol-and-aldosterone-in-hypertensive-nephropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:58:32Z","timestamp":1757674712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402290-the-role-of-cortisol-and-aldosterone-in-hypertensive-nephropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.92130","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}